| 000 | 01517 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511215326.0 | ||
| 264 | 0 | _c19910410 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.1991.tb07953.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaso, R | |
| 245 | 0 | 0 |
_aAntithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cJan 1991 |
||
| 300 |
_a87-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAntithrombin III _xgenetics |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCodon _xgenetics |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aThrombin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThrombophlebitis _xblood |
| 700 | 1 | _aLane, D A | |
| 700 | 1 | _aThompson, E A | |
| 700 | 1 | _aOlds, R J | |
| 700 | 1 | _aThein, S L | |
| 700 | 1 | _aPanico, M | |
| 700 | 1 | _aBlench, I | |
| 700 | 1 | _aMorris, H R | |
| 700 | 1 | _aFreyssinet, J M | |
| 700 | 1 | _aAiach, M | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 77 _gno. 1 _gp. 87-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.1991.tb07953.x _zAvailable from publisher's website |
| 999 |
_c2004784 _d2004784 |
||